Timing of FSH-stimulation and follicular development in cryopreserved human ovarian grafts

Author： Van den Broecke Rudy Liu Jun Van der Elst Josiane Dhont Marc

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.4, Iss.1, 2002-01, pp. : 21-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix

By Asimakopoulos Byron Nikolettos Nikos Al-Hasani Safaa

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 52-56

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation

By Pang S Kaplan B Karande V Westphal LM Scott R Givens C Sacks P

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 319-326

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

FSH and folliculogenesis: from physiology to ovarian stimulation

By Vegetti Walter Alagna Federica

Reproductive BioMedicine Online, Vol. 12, Iss. 6, 2006-06 ,pp. : 684-694

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles

By Platteau Peter Nyboe Andersen Anders Loft Anne Smitz Johan Danglas Pascal Devroey Paul

Reproductive BioMedicine Online, Vol. 17, Iss. 2, 2008-08 ,pp. : 190-198

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication

By Engel Jörg B Felberbaum Ricardo E Reissmann Thomas Kose R Diedrich Klaus

Reproductive BioMedicine Online, Vol. 3, Iss. 2, 2001-09 ,pp. : 104-108

Reproductive Healthcare Ltd

Access to resources Recommend Favorite